Second, ERCC1 polymorphisms might also play roles in predicting the risk of cervical cancer and the toxicities that underwent cisplatin treatment, but whether these polymorphisms function in patients’ survival has not been elucidated. This evidence concerns the gene ERCC1 and cervical carcinoma.